Net sales — Total revenues
Incyte Net sales — Total revenues decreased by 9.7% to $1.10B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.8%, from $922.27M to $1.10B. Over 4 years (FY 2021 to FY 2025), Net sales — Total revenues shows an upward trend with a 17.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates strong market adoption and successful commercialization of the drug portfolio, while a decrease may signal increased competition, patent expirations, or loss of market share.
Detailed definition
This metric represents the total gross revenue generated from the sale of pharmaceutical products after accounting for r...
Peer comparison
Comparable to net product revenue reported by other biopharmaceutical companies, often benchmarked against consensus analyst estimates for specific therapeutic franchises.
incy_segment_net_sales_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $575.15M | $594.01M | $648.04M | $605.82M | $663.85M | $713.01M | $764.22M | $693.24M | $827.01M | $783.20M | $861.73M | $729.92M | $906.57M | $962.99M | $1.02B | $922.27M | $1.06B | $1.15B | $1.22B | $1.10B |
| QoQ Change | — | +3.3% | +9.1% | -6.5% | +9.6% | +7.4% | +7.2% | -9.3% | +19.3% | -5.3% | +10.0% | -15.3% | +24.2% | +6.2% | +5.9% | -9.5% | +14.9% | +8.5% | +6.3% | -9.7% |
| YoY Change | — | — | — | — | +15.4% | +20.0% | +17.9% | +14.4% | +24.6% | +9.8% | +12.8% | +5.3% | +9.6% | +23.0% | +18.3% | +26.4% | +16.9% | +19.4% | +20.0% | +19.8% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Incyte's net sales — total revenues?
- Incyte (INCY) reported net sales — total revenues of $1.10B in Q1 2026.
- How has Incyte's net sales — total revenues changed year-over-year?
- Incyte's net sales — total revenues increased by 19.8% year-over-year, from $922.27M to $1.10B.
- What is the long-term trend for Incyte's net sales — total revenues?
- Over 4 years (2021 to 2025), Incyte's net sales — total revenues has grown at a 17.0% compound annual growth rate (CAGR), from $2.32B to $4.35B.
- What does net sales — total revenues mean?
- The total amount of money earned from selling pharmaceutical products after accounting for discounts and returns.